Venoms to Drugs

Venom from cone snails, scorpions, spiders, snakes and other species continue to provide an immense reservoir of potent bioactive peptides that target specific enzymes, ion channels and receptors. As such they represent major sources of lead compounds for both the development of pharmacological tools and novel drugs

 Opening Plenary: 

A/Professor Kathy Belov  

Proposed Talk: Unravelling the secrets of an enigmatic Australian: Platypus Venom

Faculty of Veterinary Science, University of Sydney, Australia


Keynote Addresses: 

Associate Professor Greta Binford

Proposed Talk: The phylogenetic scale of venom variation in Sicariid Spiders

Associate Professor of Biology: Department of Biology, Lewis and Clark College of Arts and Sciences, USA   


Professor Juan Calvete

Proposed Talk: The strange case of the RPTLN gene

Instituto de Biomedicina de Valencia, Spain


Professor David Craik

Proposed Talk: Running rings around toxins

Group Leader: Institute for Molecular Bioscience, University of Queensland, Australia


Associate Professor Bryan Fry

Proposed Talk: Venom Breathing Dragons: Novel toxins from Anguimorpha lizards

Group Leader: University of Queensland, Australia


Professor Wayne Hodgson

Proposed Talk: The cardiovascular effects of Australasian animal venoms: Mechanisms of action and treatment strategies

Head (Teaching & Research Training), Department of Pharmacology, & Director MBBS Admissions, Faculty of Medicine, Nursing & Health Sciences, Monash University, Australia


Dr Stephan Kellenberger

Proposed Talk: Structure and function of acid-sensing ion channel ASICs

Group Leader: Pharmacology and Toxicology Department, University of Lausanne, Switzerland


Professor Martin Lavin

Proposed Talk: A Venomics Program: From molecules to applications

Group Leader: UQ Centre for Clinical Research, University of Queensland, Australia


Professor Richard Lewis

Proposed Talk: Discovery and development of x-conopeptides for pain

 Group Leader: Institute for Molecular Bioscience, University of Queensland, Australia 


Professor Kini R Manjunatha  

Proposed Talk: New toxins from snake venoms

Professor: Department of Natural Science, National University of Singapore, Singapore


Dr John L McIntyre

Proposed Talk: Uses of Spider Peptides for Crop Protection

President and CEO: Vestaron Corporation, USA


Professor Ray Norton

Proposed Talk: Conotoxins targeting voltage-gated sodium channels: designing new analgesics

Monash Institute of Pharmaceutical Sciences, Monash University, Australia


Dr Daniel Obrecht

Proposed Talk: From the natural antibiotic protegrin to the clinical candidate POL7080

Co-founder and Chief Scientific Officer of Polyphor Ltd., Switzerland


Professor Baldomero Olivera

Proposed Talk: Venoms as natural product libraries: Conopeptides, a case study

Distinguished Professor: Department of Biology, The University of Utah, USA


Dr Mike Pennington

Proposed Talk: Advancing ShK peptide into the clinic for treatment of Multiple Sclerosis

Chief Technology Officer: Peptides International Inc., US


Dr Birgit Priest

Proposed Talk: Pros and cons of Peptide Toxins as proof-of-concept molecules for ion channel targets

Research Advisor: Eli Lilly and Company, USA


Dr Reto Stocklin   

Proposed Talk: CONCO: The cone snail genome project for health

President and CEO: Atheris Laboratories, Switzerland


Dr Palmer Taylor    

Proposed Talk: Natural products and soluble receptor surrogates as models and templates in drug design

Dean, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, USA


Dr Alan Wickenden  

Proposed Talk: Sodium channel drug discovery: Challenges and opportunities

Research Fellow: Johnson & Johnson PRD, USA